Phase I Trial of Oral Topotecan Plus Temodar in the Treatment of Patients With Malignant Gliomas.

Trial Profile

Phase I Trial of Oral Topotecan Plus Temodar in the Treatment of Patients With Malignant Gliomas.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Oct 2013

At a glance

  • Drugs Temozolomide (Primary) ; Topotecan (Primary)
  • Indications Glioma
  • Focus Adverse reactions
  • Most Recent Events

    • 21 Nov 2012 Planned end date changed from 1 Jul 2012 to 1 Mar 2013 as reported by ClinicalTrials.gov.
    • 01 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Sep 2011 Planned end date changed from 1 Dec 2009 to 1 Jul 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top